Scholarly article on di-(neophyl)-mercury 35293-34-6 from Journal of the American Chemical Society p. 3747,3751

DOI: 10.1021/ja01619a021

Source and publish data:

Journal of the American Chemical Society p. 3747,3751 (1955)

Update date:2022-08-04

Topics:

Authors:

Winstein

Traylor Traylor

Read Full Text PDF DownLoad Join now for total 90,000,000 free articles

Article abstract of DOI:10.1021/ja01619a021

Full text of DOI:10.1021/ja01619a021

Products guided by the article

Product name:di-(neophyl)-mercury

Cas No:35293-34-6

R&D Labs maybe for 35293-34-6

Jiangsu Fengshan Group Co., Ltd.

Contact:86-25-86558671

Address:1903,Central International Mansion 105-6 North Zhongshan Road, Nanjing, China
Wuhan Hanye Chemical New Material Co.,Ltd

Contact:+86-27-85308141

Address:LiuDian, Panlongcheng Economic Development Zone, HuangPi district, Wuhan, Hubei 430311 P.R.China
ZHANGJIAGANG FREE TRADE ZONE YONG HAN INTERNATIONAL TRADING CO., LTD(expird)

Contact:86 512 57910558

Address:qianjin M road
NEW FORTUNE INDUSTRIAL CO.,LTD.

website:http://newfortune.lookchem.com/

Contact:+86-25-8645-9456

Address:C4-105 GREEN ISLAND FLOWER TOWN
SINFACHEM LIMITED

Contact:86-25-84683399

Address:605, Phoenix Herui Plaza, No.389, South Taiping Road, Nanjing, China 210002

Relevant to this article

An extraordinary isotope effect in a carbene rearrangement

Doi:10.1016/S0040-4039(00)74240-7
(1992)
antihypertensive and monoamine oxidase inhibitory activity of some azacycloalkyl-substituted benzaldehyde hydrazone derivatives.

Doi:10.1021/jm00292a004
(1971)
Reactions of group IV organometallic compounds XXV. Preparations and reactions of tetramethylene-[(α-trimethylsilyl- or α-trimethylstannyl)phenacyl]sulphonium salts and ylides

Doi:10.1016/S0022-328X(00)88286-8
(1972)
BIOSYNTHESIS OF HYGRINE FROM <5-14C>ORNITHINE VIA A SYMMETRICAL INTERMEDIATE IN NICANDRA PHYSALOIDES

Doi:10.1016/S0031-9422(00)83160-X
(1985)
Design, synthesis and biological evaluation of novel 1H-1,2,4-triazole, benzothiazole and indazole-based derivatives as potent FGFR1 inhibitors viafragment-based virtual screening

Doi:10.1080/14756366.2019.1673745
(2020)
Doi:10.1246/bcsj.44.3469
(1971)

Article Doi

DOI: 10.1021/ja01619a021